Safety of intravenously applied mistletoe extract - results from a phase I dose escalation study in patients with advanced cancer.

about

Safety of intravenously applied mistletoe extract - results from a phase I dose escalation study in patients with advanced cancer.

Item

http://www.wikidata.org/entity/Q41704754

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Safety of intravenously applie ...... patients with advanced cancer.

@en

type

Item

label

Safety of intravenously applie ...... patients with advanced cancer.

@en

prefLabel

Safety of intravenously applie ...... patients with advanced cancer.

@en

P1476

Safety of intravenously applie ...... patients with advanced cancer.

@en

P2093

Carola Effertz

http://www.w3.org/2001/XMLSchema#string

Dietrich Schlodder

http://www.w3.org/2001/XMLSchema#string

Roman Huber

http://www.w3.org/2001/XMLSchema#string

Sabine Rieger

http://www.w3.org/2001/XMLSchema#string

Wilfried Tröger

http://www.w3.org/2001/XMLSchema#string

P2860

Mistletoe therapy in oncology

Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects.

Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer.

Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study.

Abnormality on liver function test

Mistletoe lectin transport by M-cells in follicle-associated epithelium (FAE) and IL-12 secretion in dendritic cells situated below FAE in vitro.

Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.

Pharmacokinetics of natural mistletoe lectins after subcutaneous injection.

The influence of isorel on the advanced colorectal cancer.

Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects.

P2888

s12906-017-1971-1

P304

465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12906-017-1971-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091834917

http://www.w3.org/2001/XMLSchema#string

P698

28923036

http://www.w3.org/2001/XMLSchema#string

P932

5604151

http://www.w3.org/2001/XMLSchema#string